Vericel Corp. (VCEL)
39.89
-1.06
(-2.59%)
USD |
NASDAQ |
Aug 31, 16:00
39.89
0.00 (0.00%)
After-Hours: 18:40
Vericel Cash from Operations (Annual) : 51.91M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 51.91M |
| December 31, 2024 | 58.16M |
| December 31, 2023 | 35.31M |
| December 31, 2022 | 16.61M |
| December 31, 2021 | 29.04M |
| December 31, 2020 | 17.57M |
| December 31, 2019 | -7.183M |
| December 31, 2018 | -0.412M |
| December 31, 2017 | -13.18M |
| December 31, 2016 | -19.89M |
| December 31, 2015 | -13.35M |
| December 31, 2014 | -25.41M |
| December 31, 2013 | -19.94M |
| December 31, 2012 | -29.54M |
| December 31, 2011 | -24.49M |
| Date | Value |
|---|---|
| December 31, 2010 | -9.252M |
| June 30, 2009 | -13.80M |
| June 30, 2008 | -19.53M |
| June 30, 2007 | -14.83M |
| June 30, 2006 | -13.52M |
| June 30, 2005 | -11.06M |
| June 30, 2004 | -9.525M |
| June 30, 2003 | -8.99M |
| June 30, 2002 | -8.749M |
| June 30, 2001 | -6.362M |
| June 30, 2000 | -6.877M |
| June 30, 1999 | -11.20M |
| June 30, 1998 | -15.64M |
| June 30, 1997 | -13.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AbbVie, Inc. | 19.03B |
| ADMA Biologics, Inc. | 50.40M |
| Kyntra Bio, Inc. | -4.82M |
| Conexeu Sciences, Inc. | -1.67M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |